Avenue

REEP Equity Releases Comprehensive Guide to Multifamily Real Estate Investing

Retrieved on: 
Wednesday, August 9, 2023

SAN ANTONIO, Aug. 9, 2023 /PRNewswire/ -- The world of investment offers an array of opportunities, ranging from traditional stocks and bonds to the ever-evolving world of cryptocurrencies and commodities. One particularly promising avenue is multifamily real estate investments in the United States. However, like any investment venture, it comes with inherent risks that necessitate thorough research and understanding before making any decisions.

Key Points: 
  • One particularly promising avenue is multifamily real estate investments in the United States.
  • REEP Equity , a leading multifamily real estate firm with its own in-house management company, recognizes the significance of having a reliable and compatible investment partner.
  • To assist investors in navigating the process and making informed decisions, REEP Equity has released a free comprehensive guide titled " Your Guide to Multifamily Investing: Unlock the Benefits & Discover How to Select the Right Investment Partner ."
  • Choosing the right investment partner is crucial to achieving success," said Jacob Garza, Co-Founder of REEP Equity.

Avenue Therapeutics Announces High Potency and Full Efficacy in a Model of Generalized Seizures for its Novel GABA-A Receptor Potentiator, BAER-101, Supporting Phase 2 Clinical Study

Retrieved on: 
Tuesday, August 1, 2023

The GAERS model mimics behavioral, electrophysiological and pharmacological features of human absence seizures.

Key Points: 
  • The GAERS model mimics behavioral, electrophysiological and pharmacological features of human absence seizures.
  • The GAERS model is a proven, early, informative indicator of efficacy in anti-seizure drug development, with high predictability of response in humans.
  • In the model, BAER-101 demonstrated full suppression of seizure activity with a minimal effective dose of 0.3 mg/kg, PO.
  • The combination of safety, tolerability and efficacy in an established translationally relevant epilepsy model support BAER-101’s continued development.

Avenue Therapeutics Announces First Patient Dosed in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)

Retrieved on: 
Thursday, July 27, 2023

MIAMI, July 27, 2023 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced that the first patient has been dosed in the Phase 1b/2a clinical trial of AJ201 for the treatment of spinal and bulbar muscular atrophy (“SBMA”), also known as Kennedy's Disease.

Key Points: 
  • MIAMI, July 27, 2023 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced that the first patient has been dosed in the Phase 1b/2a clinical trial of AJ201 for the treatment of spinal and bulbar muscular atrophy (“SBMA”), also known as Kennedy's Disease.
  • “We are excited to announce that the first patient has been dosed in our Phase 1b/2a clinical trial evaluating AJ201 for the treatment of SBMA, a progressive and devastating neurodegenerative disease that currently has no approved treatments available,” said Alexandra MacLean, M.D., Chief Executive Officer of Avenue.
  • “We are encouraged by the Phase 1 clinical data of AJ201 that demonstrate the drug’s excellent safety profile in healthy volunteers.
  • The primary endpoint of the study is to assess safety and tolerability of AJ201 in subjects with clinically and genetically defined SBMA.

Avenue Therapeutics Announces Agreement with the FDA on the Study Design and Analysis Approach of the Phase 3 Safety Study for IV Tramadol

Retrieved on: 
Tuesday, July 25, 2023

The agreed upon non-inferiority study is designed to assess the theoretical risk of opioid-induced respiratory depression related to opioid stacking on IV tramadol compared to IV morphine.

Key Points: 
  • The agreed upon non-inferiority study is designed to assess the theoretical risk of opioid-induced respiratory depression related to opioid stacking on IV tramadol compared to IV morphine.
  • The study will randomize post bunionectomy patients to IV tramadol or IV morphine for pain relief administered during a 48-hour post-operative period.
  • Of note, IV tramadol demonstrated safety and efficacy in this same surgical model in a Phase 3 efficacy trial.
  • We remain committed to Avenue’s mission of delivering impactful therapies to treat patients with neurologic diseases, while building shareholder value,” said Dr. MacLean.

Piedmont Office Realty Trust Announces Pricing of Senior Notes Offering

Retrieved on: 
Tuesday, July 18, 2023

Atlanta, July 18, 2023 (GLOBE NEWSWIRE) -- Piedmont Office Realty Trust, Inc. (the “Company” or “Piedmont”) (NYSE:PDM) announced today that its operating partnership, Piedmont Operating Partnership, LP (the “Operating Partnership”), has priced an offering of $400 million aggregate principal amount of 9.250% senior unsecured notes due 2028 at 99.000% of the principal amount.

Key Points: 
  • Atlanta, July 18, 2023 (GLOBE NEWSWIRE) -- Piedmont Office Realty Trust, Inc. (the “Company” or “Piedmont”) (NYSE:PDM) announced today that its operating partnership, Piedmont Operating Partnership, LP (the “Operating Partnership”), has priced an offering of $400 million aggregate principal amount of 9.250% senior unsecured notes due 2028 at 99.000% of the principal amount.
  • The offering is expected to close on July 20, 2023, subject to the satisfaction of customary closing conditions.
  • Piedmont intends to use the net proceeds from the offering, together with cash on hand, if necessary, to fund the purchase of all of its outstanding 4.45% senior notes due 2024 that are validly tendered and accepted for purchase in the tender offer commenced substantially concurrently with the offering.
  • The notes will be fully and unconditionally guaranteed on a senior unsecured basis by the Company.

Hasbro Celebrates its 100th Anniversary at 2023 San Diego Comic-Con International

Retrieved on: 
Monday, July 17, 2023

"We are absolutely thrilled to celebrate our 100th anniversary with our fans at San Diego Comic-Con," said Kim Boyd, Head of Toy at Hasbro.

Key Points: 
  • "We are absolutely thrilled to celebrate our 100th anniversary with our fans at San Diego Comic-Con," said Kim Boyd, Head of Toy at Hasbro.
  • Attendees can visit the Hasbro Pulse Desk at the Hasbro Booth (#3213) to receive a one-time use code, which can be scanned to pre-order.
  • Programming - In addition to hosting several insightful brand panels at San Diego Comic-Con (SDCC), Hasbro has a powerhouse programming schedule planned at its booth to help attendees have a memorable convention experience.
  • Hasbro is hosting The VAULT: A Hasbro Pulse Store at the Sparks Gallery (530 Sixth Avenue) so fans can purchase Hasbro Pulse’s best-selling products and select convention exclusives.

Avenue Bellevue Sets New Record With $14.35M Penthouse Sale

Retrieved on: 
Tuesday, July 11, 2023

Interest remains high for Bellevue’s newest luxury condo buildings – Avenue Estates and Avenue Residences, including three notable penthouse sales.

Key Points: 
  • Interest remains high for Bellevue’s newest luxury condo buildings – Avenue Estates and Avenue Residences, including three notable penthouse sales.
  • View the full release here: https://www.businesswire.com/news/home/20230711749967/en/
    Render by Avenue Bellevue (Photo: Business Wire)
    Avenue Estates has set a new price record with both the sale price and price per square foot (PPSF) with the sale of a penthouse home at $14.35M – over $3,000 PSF.
  • Avenue’s record setting presales showcase the sought-after location, lifestyle and value Avenue Bellevue offers.
  • “Avenue Bellevue presents an unparalleled living experience, with the best in dining, shopping, amenities, and services in a world-class setting.

W HOTELS UNVEILS A BOLD DUALITY IN HUNGARY'S HISTORIC CAPITAL WITH DEBUT OF W BUDAPEST

Retrieved on: 
Monday, July 10, 2023

Following the 2021 opening of W Rome, W Budapest showcases the evolved direction of W Hotels, offering incredible design in an elevated and sophisticated yet playful setting that intrinsically connects the next generation of luxury travellers to the locale.

Key Points: 
  • Following the 2021 opening of W Rome, W Budapest showcases the evolved direction of W Hotels, offering incredible design in an elevated and sophisticated yet playful setting that intrinsically connects the next generation of luxury travellers to the locale.
  • "The debut of W Hotels in Budapest marks a monumental milestone and signals a new era of design ethos for our iconic brand," said George Fleck, Vice President and Global Brand Leader, W Hotels.
  • Located on the ground floor, seamlessly blending into Nightingale restaurant, is W Lounge – the social epicentre of the hotel.
  • Passionate programming will include FACES OF BUDAPEST, kicking off in August in celebration of Budapest Fashion Week.

Bevel Acquired by The Avenue Z Network to Build First Digital Communications Unicorn

Retrieved on: 
Thursday, July 6, 2023

Bevel , the top communications consultancy for tech and venture capital, today announced its acquisition by Avenue Z , founded by digital visionary Jeffrey Herzog, to build the first strategic communications unicorn.

Key Points: 
  • Bevel , the top communications consultancy for tech and venture capital, today announced its acquisition by Avenue Z , founded by digital visionary Jeffrey Herzog, to build the first strategic communications unicorn.
  • “I’m excited to work with Jeff Herzog to build the first digital communications unicorn,” said Jessica Schaefer, Founder and CEO of Bevel.
  • WIth new capabilities from Avenue Z, Bevel will now offer greater influence through Search & Social Media.
  • Avenue Z is actively expanding and plans to acquire firms across digital marketing, branding, analytics and technology.

Hong Kong International Dragon Boat Races Return

Retrieved on: 
Tuesday, June 27, 2023

The Hong Kong International Dragon Boat Races jointly organized by the Hong Kong Tourism Board (HKTB) and the Hong Kong China Dragon Boat Association (HKCDBA) took place June 24-25.

Key Points: 
  • The Hong Kong International Dragon Boat Races jointly organized by the Hong Kong Tourism Board (HKTB) and the Hong Kong China Dragon Boat Association (HKCDBA) took place June 24-25.
  • The event welcomed first-time participants from Poland, Australia, Dubai, Japan, Malaysia, Thailand, the Philippines, Mainland China, Macao, and Hong Kong.
  • View the full release here: https://www.businesswire.com/news/home/20230627108445/en/
    More than 160 teams of about 4,000 dragon boat athletes from ten countries and regions participated in the Hong Kong International Dragon Boat Races to compete for 17 titles in Victoria Harbour.
  • Visitors are welcome to visit the LINE FRIENDS Hello Hong Kong Dragon Boat Photo Spots, and the themed POP-UP STORE at Avenue of the Stars in Tsim Sha Tsui until July 2.